Disease progression from steatosis to NASH in patients correlated with increased c-Jun expression in hepatocytes, while its expression in non-parenchymal liver cells (NPLCs) particularly correlated with fibrosis. This evidence concerns the gene JUN and metabolic dysfunction-associated steatohepatitis.